Table 3.
Study variables | Baseline (n=42) | At hospital admission (n=91) | At ACS diagnosis (n=91) | At PICU admission (n=9) | 24 h prior to hospital discharge (n=91) |
---|---|---|---|---|---|
WBC (k/mL), median (IQR)* | 12 (9.75–17.75) (n=29) | 19.2 (13.36–26) (n=90) | 18.2 (13.4–24.48) (n=86) | 23.3 (12.45–39.35) (n=9) | 10.95 (7.95–14.85) (n=34) |
Neutrophil (%), mean±SD* | 40.59±14.56 (n=23) | 59.72±16.39 (n=66) | 60.44±16.57 (n=64) | 72.36±15.63 (n=7) | 41.52±16.41 (n=23) |
Lymphocyte (%), mean±SD* | 43.69±16.24 (n=27) | 26.35±13.12 (n=85) | 25.93±13.43 (n=82) | 18.97±10.92 (n=7) | 41.04±16.67 (n=25) |
Hemoglobin (g/dL), mean±SD* | 8.28±0.88 (n=31) | 7.56±1.37 (n=88) | 7.50±1.42 (n=84) | 7.57±2.56 (n=9) | 9.28±0.94 (n=35) |
Reticulocyte (%), median (IQR)* | 9 (6.5–13) (n=31) | 9.6 (6.4–12.5) (n=83) | 8.5 (6.05–12.4) (n=77) | 6.3 (1.9–14.3) (n=7) | 4.4 (1.75–8.9) (n=21) |
Platelets (k/mL), mean±SD* | 410.9±184.15 (n=30) | 369.75±173.24 (n=88) | 355.47±172.34 (n=85) | 311.78±151.41 (n=9) | 534.18±316.23 (n=34) |
LDH (U/L), mean±SD* | 519.5±184.55 (n=12) | 543.3±165.75 (n=46) | 554.3±187.45 (n=43) | 619.2±335.42 (n=5) | 480.75±217.61 (n=4) |
Positive CRP-qualitative, n (%)* | N/A | 66 (89.2) (n=74) | 68 (95.8) (n=71) | 6 (85.7) (n=7) | 7 (100) (n=7) |
Blood culture, n (%)* | N/A | Positive: 5 | N/A | N/A | N/A |
N egative: 76 | |||||
Missi n g: 10 | |||||
Hb S (%), median (IQR)* | 77.45 (69.8–84.025) (n=6) | 73.3 (57.7–82.025) (n=20) | N/A | N/A | N/A |
Hb F (%), median (IQR)* | 16.45 (8.2–21.1) (n=6) | 8 (5.5–18.8) (n=19) | N/A | N/A | N/A |
*Missing details were excluded. ACS=Acute chest syndrome, PICU=Pediatric intensive care unit, WBC=White blood cells, IQR=Interquartile range, SD=Standard deviation, LDH=Lactate dehydrogenase, CRP=C-reactive protein, N/A=Not applicable